Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?

The outcome and quality of life of chronic myeloid leukemia (CML) patients has remarkably changed with the treatment of tyrosine kinase inhibitors (TKIs). Currently, hematopoietic stem cell transplantation (HSCT) is considered mainly as a third line salvage therapy in cases of TKIs resistance or int...

Descrición completa

Detalles Bibliográficos

Principais autores:	Avital F. Barak, Lilach Bonstein, Roy Lauterbach, Elizabeth Naparstek, Sigal Tavor
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2011-12-01
Series:	Hematology Reports
Assuntos:	chronic myeloid leukemia, tyrosine kinase inhibitor, thrombocytopenia, HSCT
Acceso en liña:	http://www.pagepress.org/journals/index.php/hr/article/view/3322
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!